These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23214096)

  • 21. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
    Kobayashi S; Kanai Y
    Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts in the management of rheumatoid arthritis.
    Murphy NG
    Del Med J; 1992 Apr; 64(4):257-64. PubMed ID: 1352263
    [No Abstract]   [Full Text] [Related]  

  • 23. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 24. Superficial Tissue Necrosis Related to Methotrexate Injection in a Patient With Rheumatoid Arthritis.
    Estrada Alarcon PV; García-Díaz S; Oña M; Corominas H
    J Clin Rheumatol; 2015 Oct; 21(7):370. PubMed ID: 26398466
    [No Abstract]   [Full Text] [Related]  

  • 25. Safe prescribing of methotrexate for rheumatoid arthritis.
    Kirkham BW
    Med J Aust; 1995 Sep; 163(5):278. PubMed ID: 7565224
    [No Abstract]   [Full Text] [Related]  

  • 26. The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving stable background methotrexate or sulfasalazine.
    van Vollenhoven RF; Houbiers JG; Buttgereit F; In 't Hout J; Boers M; Leij S; Kvien TK; Dijkmans BA; Szczepański L; Szombati I; Sierakowski S; Miltenburg AM
    Arthritis Rheum; 2010 Feb; 62(2):351-8. PubMed ID: 20112368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prednisone Use and Risk of Mortality in Patients With Rheumatoid Arthritis: Moderation by Use of Disease-Modifying Antirheumatic Drugs.
    Chester Wasko M; Dasgupta A; Ilse Sears G; Fries JF; Ward MM
    Arthritis Care Res (Hoboken); 2016 May; 68(5):706-10. PubMed ID: 26415107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effective combination therapy of TNF antagonists with DMARDs].
    Ohtsubo H; Matsuda T
    Nihon Rinsho; 2007 Jul; 65(7):1287-91. PubMed ID: 17642245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and treatment of rheumatoid arthritis].
    Misiūniene N; Baranauskaite A
    Medicina (Kaunas); 2002; 38(1):110-6. PubMed ID: 12474726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What dose of folic acid to use with methotrexate in rheumatoid arthritis?
    Bramley D
    Drug Ther Bull; 2021 Jul; 59(7):103-106. PubMed ID: 34162667
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 2003 Jan; 128(4):147-9. PubMed ID: 12589584
    [No Abstract]   [Full Text] [Related]  

  • 32. Salazosulfapyridine-induced hypersensitivity syndrome triggered by methotrexate.
    Teraki Y; Izaki S
    Clin Exp Dermatol; 2009 Oct; 34(7):e287-8. PubMed ID: 19438549
    [No Abstract]   [Full Text] [Related]  

  • 33. Disease activity trajectories in early rheumatoid arthritis following intensive DMARD therapy over 3 years: association with persistence to therapy.
    Wabe N; Wojciechowski J; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Proudman S; Wiese MD
    Int J Rheum Dis; 2017 Oct; 20(10):1447-1456. PubMed ID: 28952204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disease modifying anti-rheumatic drugs (DMARDs): an overview].
    Kawabata D; Mimori T
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():489-92. PubMed ID: 15799404
    [No Abstract]   [Full Text] [Related]  

  • 35. Low-dose tacrolimus with methotrexate repairs rheumatoid fingers.
    Nishioka Y
    Intern Med; 2011; 50(21):2703-4. PubMed ID: 22041392
    [No Abstract]   [Full Text] [Related]  

  • 36. Parenteral methotrexate for the treatment of rheumatoid arthritis.
    Yazici Y; Bata Y
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy for rheumatoid arthritis: new paradigms of treatment.
    Wilke WS
    Cleve Clin J Med; 1993; 60(2):101-2. PubMed ID: 8095190
    [No Abstract]   [Full Text] [Related]  

  • 38. Methotrexate-related minor adverse effects in rheumatoid arthritis: more than a nuisance.
    Dhir V; Aggarwal A
    J Clin Rheumatol; 2012 Jan; 18(1):44-6. PubMed ID: 22157277
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: an 11-year experience from the FIN-RACo Trial.
    Karstila KL; Rantalaiho VM; Mustonen JT; Möttönen TT; Hannonen PJ; Leirisalo-Repo M; Kaipiainen-Seppänen OA; Karjalainen AH; Korpela MM;
    Clin Exp Rheumatol; 2010; 28(1):73-8. PubMed ID: 20346242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.